Related Experiment Video
Updated: Jun 20, 2026
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
Effective Reduction in Nuclear DNA Contamination Allows Sensitive Mitochondrial DNA Methylation Determination by
Lin Liang1, Luis Alfonso González Molina1,2, Pytrick G Jellema1
1Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Abstract:
Mitochondria are essential organelles for cellular energy production, playing a central role in driving metabolic processes and supporting critical intracellular functions. Neurometabolic disorders encompass a wide variety of conditions characterized by mitochondrial dysfunction. Owing to their bacterial ancestry, mitochondria possess an independent genome consisting of a circular DNA molecule (mtDNA), which has been reported to be subject to methylation. However, the technical challenges in the detection of mtDNA methylation have led to debates on its existence. One of the concerns is that the compactness of mtDNA can lead to suboptimal bisulfite conversion, thereby causing mtDNA methylation overestimation. To address this, liquid chromatography tandem mass spectrometry (LC-MS/MS) offers a bisulfite-independent readout; however, this method requires mtDNA samples devoid of nuclear DNA (nDNA) contamination. To diminish nDNA contamination, we isolated mtDNA from the TRIzol RNA phase. Importantly, pyrosequencing showed no significant difference in the methylation levels of mtDNA isolated from the TRIzol RNA phase compared to those from the TRIzol DNA phase, or isolated via total genomic DNA (gDNA). Across different human cell lines, LC-MS/MS detected significantly lower global methylation levels for DNA isolated from the TRIzol RNA phase than those from the TRIzol DNA or gDNA isolation. Moreover, using mtDNA isolated from the TRIzol RNA phase, LC-MS/MS validated the enhanced mtDNA methylation in HepG2 transgenic cell lines expressing mitochondrial-targeted DNA methyltransferases (means of 2.89% and 2.03% for MCviPI and MSssI transgenic cell lines, respectively), compared to two negative control cell lines (1.36 and 1.39%). When applying it to clinically relevant material, LC-MS/MS demonstrated a significantly lower global methylation level for platelet DNA isolated from the TRIzol RNA phase (mean of 1.98%) compared to gDNA isolations (mean of 4.32%). Similar findings were confirmed in mouse brain tissue, in which a significantly lower methylation level was detected in DNA isolated from the TRIzol RNA phase (1.79%) compared to that from gDNA isolation (5.12%). In conclusion, isolating mtDNA from the TRIzol RNA phase holds significant potential in future studies, particularly for the quantification of mtDNA global methylation by LC-MS/MS, a technique that is independent of bisulfite conversion and bioinformatic analysis.
Insights
Researchers developed a new method to accurately measure mitochondrial DNA (mtDNA) methylation using liquid chromatography tandem mass spectrometry (LC-MS/MS). This technique, by isolating mtDNA from the TRIzol RNA phase, overcomes previous challenges and provides reliable methylation quantification.
Area of Science:
- Cellular Biology
- Genetics
- Biochemistry
Background:
- Mitochondria are vital organelles for cellular energy and metabolism.
- Mitochondrial dysfunction is linked to neurometabolic disorders.
- Mitochondrial DNA (mtDNA) methylation is debated due to technical detection challenges, including overestimation from bisulfite conversion issues.
Purpose of the Study:
- To establish a reliable method for quantifying mtDNA methylation.
- To address the challenges of detecting mtDNA methylation, particularly nuclear DNA (nDNA) contamination.
- To validate a bisulfite-independent approach for accurate mtDNA methylation analysis.
Main Methods:
- Isolation of mtDNA from the TRIzol RNA phase to minimize nDNA contamination.
- Utilizing liquid chromatography tandem mass spectrometry (LC-MS/MS) for bisulfite-independent mtDNA methylation detection.
- Comparing methylation levels from TRIzol RNA phase isolation with TRIzol DNA phase and total genomic DNA (gDNA) isolations.
Main Results:
- Isolation of mtDNA from the TRIzol RNA phase significantly reduced global DNA methylation levels detected by LC-MS/MS compared to gDNA isolations in cell lines, platelets, and mouse brain tissue.
- Pyrosequencing confirmed no significant difference in mtDNA methylation levels between TRIzol RNA phase and TRIzol DNA phase/gDNA isolations.
- LC-MS/MS successfully validated enhanced mtDNA methylation in engineered cell lines and demonstrated lower methylation in clinical samples (platelets) and mouse brain tissue when using the TRIzol RNA phase method.
Conclusions:
- Isolating mtDNA from the TRIzol RNA phase is a promising strategy for accurate quantification of mtDNA global methylation.
- LC-MS/MS, combined with this isolation method, offers a robust, bisulfite-independent approach for studying mtDNA methylation.
- This technique has significant potential for future research in neurometabolic disorders and other conditions involving mitochondrial dysfunction.
